These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37333699)

  • 1. Anaesthetic concerns in post-COVID mucormycosis at a tertiary care hospital in India: An observational study.
    Lahiri S; Kundu AK; Ray M
    Indian J Anaesth; 2023 May; 67(5):471-474. PubMed ID: 37333699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perioperative anesthesia challenges and outcomes of patients with Rhino-Orbito-Cerebral Mucormycosis during the second wave of COVID-19 pandemic: An observational study.
    Kumari K; Rathod D; Meshram T; Mohammed S; Raju S; Sharma A; Chaudhary B; Bhatia P
    J Anaesthesiol Clin Pharmacol; 2023; 39(4):615-621. PubMed ID: 38269163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rhino-orbito-cerebral mucormycosis and its resurgence during COVID-19 pandemic: A review.
    Karkhur S; Soni D; Chauhan K; Sarkar D; Gautam M; Verma S; Nyodu R; Yadav N; Sharma B
    Indian J Ophthalmol; 2023 Jan; 71(1):39-56. PubMed ID: 36588206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical & medical management of ROCM (Rhino-orbito-cerebral mucormycosis) epidemic in COVID-19 era and its outcomes - a tertiary care center experience.
    Soni K; Das A; Sharma V; Goyal A; Choudhury B; Chugh A; Kumar D; Yadav T; Jain V; Agarwal A; Garg M; Bhatnagar K; Elhence P; Bhatia PK; Garg MK; Misra S
    J Mycol Med; 2022 May; 32(2):101238. PubMed ID: 34979299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perioperative Challenges in the Management of Rhino-Orbital Cerebral Mucormycosis: An Observational Study from a Tertiary Care Hospital.
    Bhalerao PM; Kuttarmare SM; Joshi S; Naik SV
    Anesth Essays Res; 2022; 16(3):331-335. PubMed ID: 36620102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A fungal epidemic amidst a viral pandemic: Risk factors for development of COVID-19 associated rhino-orbital-cerebral mucormycosis in India.
    Vasanthapuram VH; Gupta R; Adulkar N; Nair AG; Bradoo RA; Hegde R; Singh U; Tadepalli S; Mukherjee B; Kamal S; Alam MS; Rao R; Ananthakrishna S; Backiavathy V; Murthy AK; D'Cunha L; Dudeja G; Joji A; Kiran A; Koka K; Goswami Mukhopadhyay M; Nisar SP; Rao PR; Shinde CA
    Orbit; 2023 Feb; 42(1):30-41. PubMed ID: 35192435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uncontrolled diabetes mellitus exacerbated by COVID-19-induced inflammation is the risk factor for COVID-19-associated rhino-orbito-cerebral mucormycosis: A matched pair case-control study.
    Karat S; Lobo AC; Satish D; Devaraj R; Manjooran RR; Nithyanandam S
    Indian J Ophthalmol; 2022 Aug; 70(8):3096-3101. PubMed ID: 35918980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19-associated rhino-orbital-cerebral mucormycosis: A systematic review, meta-analysis, and meta-regression analysis.
    Bhattacharyya A; Sarma P; Kaur H; Kumar S; Bhattacharyya J; Prajapat M; Prakash A; Sharma S; Reddy DH; Thota P; Bansal S; Gautam BS; Medhi B
    Indian J Pharmacol; 2021; 53(6):499-510. PubMed ID: 34975140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrum of magnetic resonance imaging findings in post-COVID-19 patients presenting with rhino-orbito-cerebral mucormycosis in a teaching hospital in Malwa region of Punjab.
    Singh P; Kaur K; Jindal V; Kaur M; Kaur M; Singh N
    J Family Med Prim Care; 2022 Dec; 11(12):7788-7794. PubMed ID: 36994047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 associated rhino-orbito-cerebral mucormycosis, risk factors and outcome predictors; a multicentric study.
    Rajabi MT; Aghajani A; Rafizadeh SM; Jamshidian Tehrani M; Poursayed Lazarjani SZ; Keshmirshekan MM; Mohammadi A; Akrami A; Parandin MM; Rajabi MB; Hosseini SS; Akbari M
    Int Ophthalmol; 2023 Apr; 43(4):1375-1386. PubMed ID: 36209307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Cross-Sectional Study of First Hundred Cases of Rhino-Orbital-Cerebral Mucormycosis Admitted at a Tertiary Care Hospital.
    Poswal L; Bunkar GL; Sharma R; Jain A; Samar N; Mathur N; Singh M; Kaushik PB
    Indian J Community Med; 2022; 47(3):433-436. PubMed ID: 36438531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperglycemia and steroid use increase the risk of rhino-orbito-cerebral mucormycosis regardless of COVID-19 hospitalization: Case-control study, India.
    Ponnaiah M; Ganesan S; Bhatnagar T; Thulasingam M; Majella MG; Karuppiah M; Rizwan SA; Alexander A; Sarkar S; Kar SS; Kadhiravan T; Bhatnagar A; S PK; Pillai VM; Nair PP; Dhodapkar R; Ch Toi P; Singh R; Kasthuri N; Kumar GCP; Jaisankar S; Saini V; Kankaria A; Raj A; Goyal A; Sharma V; Khichar S; Soni K; Garg MK; Selvaraj K; B H S; Bhavana K; Bharti B; Singh CM; Chaudhary N; R V; K G; Palaninathan K; Dube S; Saxena RS; Gupta N; Rathinavel A; Priya S; Arulsundareshkumar ; Bellad SA; Kavi A; Harugop AS; Pujary K; Ballala K; Mallya SD; Prasad HM; Ravi D; Balaji NK; Hegde R; Mishra N; Ray S; Karthikeyan S; Ramalingam S; Murali A; Vaidya S; Samadhiya M; Bhojani D; Lakshmanan S; Singh SRB; Pillai N; Deepthi P; Banumathi K; Sumathi V; Ramesh D; Nissar SP; Sheikh KM; Patel MN; Shristava V; Kumar SS; Shantaraman K; Pandian RD; Murhekar M; Aggarwal R
    PLoS One; 2022; 17(8):e0272042. PubMed ID: 35939442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatality Chooses Its Path Through the Orbit: A Study of Rhino-Orbito-Cerebral Mucormycosis as a Complication of COVID-19 Infection.
    Mehfooz S; Mehrotra N; Usmani T; Raj V
    Cureus; 2022 Nov; 14(11):e31822. PubMed ID: 36579288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Retrospective Study to Evaluate the Perioperative Clinical Characteristics and Outcomes of Rhino-Orbital Cerebral Mucormycosis in COVID-19 Patients at a Tertiary Care Hospital in India.
    Kumari R; Talawar P; Tripaty DK; Singla D; Kaushal A; Sharma S; Malhotra M; Boruah P; Sangadala P; Kumar KS
    Cureus; 2023 Jul; 15(7):e41613. PubMed ID: 37565105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 Associated Mucormycosis with Newly Diagnosed Diabetes Mellitus in Young Males - A Tertiary Care Experience.
    Kapoor S; Saidha PK; Gupta A; Saini U; Satya S
    Int Arch Otorhinolaryngol; 2022 Jul; 26(3):e470-e477. PubMed ID: 35846801
    [No Abstract]   [Full Text] [Related]  

  • 16. Management Challenge of Rhino-Orbito-Cerebral Mucormycosis in Covid 19 Era: A Prospective Observational Study.
    Pippal SK; Kumar D; Ukawat L
    Indian J Otolaryngol Head Neck Surg; 2022 Oct; 74(Suppl 2):3485-3491. PubMed ID: 34722223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First report of COVID-19-associated rhino-orbito-cerebral mucormycosis in pediatric patients with type 1 diabetes mellitus.
    Diwakar J; Samaddar A; Konar SK; Bhat MD; Manuel E; Hb V; Bn N; Parveen A; Hajira SN; Srinivas D; S N
    J Mycol Med; 2021 Dec; 31(4):101203. PubMed ID: 34517273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends of rhino-orbito-cerebral mucormycosis in COVID-19 patients: An observational study.
    Singh N; Singh S; Singh P; Mishra N; Sinha BP; Shrama AK
    J Family Med Prim Care; 2022 Dec; 11(12):7891-7896. PubMed ID: 36994064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 associated Mucormycosis (CAM): Implications for perioperative physicians - A narrative review.
    Gupta A; Kayarat B; Gupta N
    Saudi J Anaesth; 2023; 17(1):58-64. PubMed ID: 37032681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rhino-orbital-cerebral mucormycosis in times of COVID-19: A neurosurgical experience.
    Singh H; Dua S; Goel A; Dhar A; Bhadauria V; Garg A; Katyar V; Sharma S; Shukla A
    Surg Neurol Int; 2021; 12():538. PubMed ID: 34754588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.